What's new

[Cyprus Times] SARS-CoV-2 also leads to a surge of cancer patients

bigstock-Mammography-test-14967482-1.jpg

SARS-CoV-2 also leads to a wave of cancer patients What the results of 39 studies from 19 countries conducted in the first year of the pandemic show

Scientists around the world are predicting a "wave" of new cases of cancer patients in the coming years, due to the impact of the current pandemic on screening diagnostic tests. In fact, evaluating the data of a new study, they warn that this is another "black chapter" opened by SARS-CoV-2, as delayed diagnoses will also result in an increase in deaths from neoplasms.

The data analysed by professors from the National and Kapodistrian University of Athens are revealing, insisting that health systems will have to readjust to the challenges of the present and the future. More specifically, Assistant Professor of Oncology Michalis Liontos, Professor of Epidemiology and Preventive Medicine Theodora Psaltopoulou and Professor of Hematology-Oncology and Dean of the National Academy of Athens University of Athens Thanos Dimopoulos present data from the largest systematic review conducted to assess the extent of the problem. In the article published in the medical journal JAMA Oncology, the researchers included the results of 39 studies from 19 countries conducted in the first year of the pandemic (2020).

They then compared the number of screenings performed in 2020 for breast, colorectal and cervical cancers with that of previous years. The systematic review showed that in the first year of the pandemic, the number of screening tests decreased for all three of these neoplasms. In particular, the global decline was 47% for breast cancer, 46% for colorectal cancer and 52% for cervical cancer.

The changes

In addition, the researchers examined changes both during the course of the health crisis and between different countries. For both breast cancer and cervical cancer, the largest decrease was observed in April 2020 and thereafter the number of screenings approached the levels of previous years. In contrast, for colorectal cancer the decrease remained throughout the year.

In terms of geographical distribution, Europe saw a larger decrease in the number of mammograms performed compared to the US, while the decrease was similar in the number of colonoscopies.

In looking for the causes, scientists attribute this particularly worrying impact of the pandemic to the fact that large proportions of citizens turn to public services for screening tests, but these are the structures most affected by the pandemic. Consequently, the reorganisation of health systems, but also the fear of infection, travel restrictions and limited access to non-emergency health services have led to a reduction in the number of screening tests. It is important to note, however, that, always according to the same data, the severity of these causes varied by geographical area.



Similarly, and as expected, as commented by the professors of EKPA, more invasive tests (e.g. the Pap test and colonoscopy) showed a higher rate of reduction than less invasive methods (e.g. mammography).

"In any case, the study data confirm the negative impact of the pandemic on screening programmes for breast, colorectal and cervical cancer especially until the first half of 2020. In the coming years, both the incidence of advanced neoplasms and mortality from the disease are expected to increase," the Greek professors warn in conclusion.

Source: in.gr


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top